Related Experiment Video
Updated: Aug 20, 2026

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models
Published on: January 27, 2023
Vascular calcification mechanisms
1Bioengineering Department, Box 351720, University of Washington, Okanogan Lane, Bagley Hall, Seattle, WA 98195, USA. ceci@u.washington.edu
Insights
Vascular calcification, linked to cardiovascular disease, is worsened by altered calcium and phosphorus balance in kidney disease. Early strategies show promise in preventing its progression.
Area of Science:
- Cardiovascular Science
- Nephrology
- Biomineralization
Background:
- Vascular calcification is a significant predictor of cardiovascular disease mortality, particularly in patients with end-stage renal disease (ESRD) or diabetes.
- It contributes to arterial stiffness and increased pulse pressure, exacerbating conditions associated with aging, diabetes, and renal insufficiency.
- Beyond its role in atherosclerosis, it's implicated in various pathological biomineralization conditions like cardiac valvulopathies and calciphylaxis.
Purpose of the Study:
- To review the mechanisms underlying vascular calcification.
- To discuss the role of mineral imbalances in ESRD patients.
- To evaluate current and future therapeutic strategies.
Main Methods:
- Literature review of identified mechanisms of vascular calcification.
- Analysis of the impact of calcium (Ca) and phosphorus (P) balance on vascular calcification in ESRD.
- Examination of the efficacy of current management strategies.
Main Results:
- Key mechanisms include loss of inhibition, induction of bone formation, circulating nucleational complexes, and cell death.
- Imbalances in Ca and P significantly promote vascular calcification in ESRD patients, contributing to high cardiovascular mortality.
- Interventions targeting Ca and P levels have shown success in halting the progression of vascular calcification.
Conclusions:
- Vascular calcification is a complex process driven by multiple mechanisms, significantly influenced by mineral imbalances in ESRD.
- Current strategies for managing Ca and P levels show promise in preventing disease progression.
- Reversal of vascular calcification remains an open question, though future research offers hope.
Abstract:
Vascular calcification is highly correlated with cardiovascular disease mortality, especially in patients with ESRD or diabetes. In addition to the devastating effects of inappropriate biomineralization seen in cardiac valvulopathies, calciphylaxis, and idiopathic arterial calcification, vascular calcification is now recognized as a marker of atherosclerotic plaque burden as well as a major contributor to loss of arterial compliance and increased pulse pressure seen with age, diabetes, and renal insufficiency. In recent years, several mechanisms to explain vascular calcification have been identified including (1) loss of inhibition, (2) induction of bone formation, (3) circulating nucleational complexes, and (4) cell death. Alterations in calcium (Ca) and phosphorus (P) balance as seen in patients with ESRD promotes vascular calcification via multiple mechanisms and may explain the alarmingly high levels of cardiovascular disease deaths in these patients. Strategies to control Ca and P levels in patients with ESRD have met with early success in preventing progression of vascular calcification. Whether or not vascular calcification can be reversed is not yet known, but exciting new studies suggest that this may be possible in the future.
Related Concept Videos
Skeleton and Calcium Homeostasis
The Bone Matrix
Coronary Artery Disease II: Pathophysiology
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...

